Search results
Results From The WOW.Com Content Network
DePuy Synthes (/ d ə ˈ p j uː /) is a franchise of orthopaedic and neurosurgery companies. Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson MedTech business segment. DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands.
Russell Sturgis Codman Jr. (June 15, 1896–June 24, 1992) was an American real estate executive who served as commissioner of the Boston Fire Department from 1946 to 1950. Early life and education [ edit ]
Synthes Holding AG (formerly Synthes-Stratec) is a multinational medical device manufacturer based in Solothurn, Switzerland and West Chester, Pennsylvania, United States. It is the world's largest maker of implants to mend bone fractures, [ 2 ] and also produces surgical power tools and advanced biomaterials .
Codman served on the Boston school committee in 1861 and 1862, in the Massachusetts Senate in 1864 and 1865, and in the Massachusetts House of Representatives from 1872 to 1875. He was the Republican nominee in the 1878 Boston mayoral election , but lost to Democrat Frederick O. Prince 52% to 47%.
Edwin Everett Codman (December 19, 1876 – April 29, 1955) was an American sculptor. His work was part of the sculpture event in the art competition at the 1932 Summer Olympics . [ 1 ] Codman committed suicide by shooting himself in 1955, after suffering from inoperable cancer for 2 years. [ 1 ]
Ogden Codman Jr. (January 19, 1863 – January 8, 1951) was an American architect and interior decorator in the Beaux-Arts styles, and co-author with Edith Wharton ...
The Employees of DePuy-Synthes are Reliably informed that the family of Revra DePuy are of Belgian Extraction, not French, and as a result the family name is not pronounced in the French Form "d-pwee," but "d-pue" this is similar to my name "Walsh" pronounced locally (Ireland south east) as "Welsh" to differentiate us for the other Walsh clans ...
At the beginning of 2011, DePuy Orthopaedics said they were phasing out the ASR Hip Implant because of declining sales, but never mentioned the high failure rate data from an Australian implant registry. In March 2011, The New York Times reported that DePuy issued its first warning to doctors and patients about the high early failure rate. [1]